Setting your location helps us to show you nearby providers and locations based on your healthcare needs.
Your Location is set to Change My Location
Cone Health wants to help you get well and stay well. This section provides tools and information to achieve good health and maintain your well-being.
Learn what community resources are available to help you get well and stay well.
View health and wellness news you can use from Cone Health providers on
View Advanced Search OptionsView All Doctors
View All Locations
Home > Patient & Family Resources > Health Library > Apolipoprotein E-4 Genetic (DNA) Test
COVID-19 Info: Vaccines | Testing | Visitor Guidelines | Stats | More
IMPORTANT NOTICE: COVID-19 testing appointments are not available at Cone Health emergency departments or urgent care locations. Click here for testing options.
Most people who develop Alzheimer's disease do not have a history of the disease in their families. But if you do have a family history of Alzheimer's disease (one or more members of a family have had the disease), then your risk of getting it is higher. When a disease is found in families, the cause could be genetic (heredity), something in the environment, lifestyle choices, or a combination of these things.
A blood test can look for a substance that seems to increase a person's risk for Alzheimer's disease. The gene is called apolipoprotein E-4 (ApoE-4). The presence of ApoE-4 cannot predict for sure whether a person will develop Alzheimer's disease. Many people who have the ApoE-4 gene do not get Alzheimer's disease, and many people who do not have the gene still develop the disease. Most experts do not consider ApoE-4 testing a necessary or useful part of evaluating a person with suspected Alzheimer's disease.
Sometimes people develop Alzheimer's disease at a young age, between the ages of 30 and 60. This is referred to as early-onset Alzheimer's disease or autosomal dominant Alzheimer's disease. It is not common (less than 5 out of 100 cases), and this form of the disease has been linked to defects in specific genes. There is a 50% risk that these genes will be passed on. A person who inherits the genetic defect will most likely develop Alzheimer's disease.
Current as of: June 16, 2021
Author: Healthwise StaffMedical Review: Anne C. Poinier MD - Internal MedicineKathleen Romito MD - Family MedicineMyron F. Weiner MD - Psychiatry, Neurology
Current as of: June 16, 2021
Author: Healthwise Staff
Medical Review:Anne C. Poinier MD - Internal Medicine & Kathleen Romito MD - Family Medicine & Myron F. Weiner MD - Psychiatry, Neurology
To learn more about Healthwise, visit Healthwise.org.
© 1995-2021 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Subscribe to our Wellness Matters e-newsletter, a monthly snapshot of the some of great wellness content from Cone Health providers.